Xiaojun Liu

Prof. Xiaojun Liu

Institute of Basic Medical Sciences Chinese Academy of Medical Sciences & School of Basic Medicine Peking Union Medical College, Beijing, China
orcid

Research Focus & Metrics

Academic Career Length

14Years (2013-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 January 2017 in Molecular Metabolism
Verified
Journal Article
Open access
YZYinliang Zhang
Yinliang Zhang
CGChao Geng
Chao Geng
XLXiaoyan Liu
Xiaoyan Liu
MLMeixia Li
Meixia Li
MGMingyue Gao
Mingyue Gao
YCYongsheng Chang
Yongsheng Chang
Celastrol was recently identified as a potential novel treatment for obesity. However, the effect of Celastrol on nonalcoholic fatty liver disease (NAFLD) remains elusive. The aim of this study is to evaluate the role of Celastrol in NAFLD. Functional studies were performed using wild-type C57BL/6J (WT) mice and liver specific Sirt1-deficient (LKO) mice. The molecular mechanism was explored in primary mouse liver and primary hepatocytes. When WT mice receiving a high-fat diet (HFD) were treated with Celastrol, reductions in body weight, subcutaneous and visceral fat content, and liver lipid droplet formation were observed, along with reduced hepatic intracellular triglyceride and serum triglyceride, free fatty acid, and ALT concentrations. Furthermore, Celastrol decreased hepatic sterol regulatory element binding protein 1c (Srebp-1c) expression, enhanced the phosphorylation of hepatic AMP-activated protein kinase α (AMPKα), and increased the expression of hepatic serine-threonine liver kinase B1 (LKB1). Additionally, Celastrol treatment improved glucose tolerance and insulin sensitivity in WT mice fed the HFD. Celastrol administration also improved the anti-inflammatory and anti-oxidative status by inhibiting nuclear factor kappa B (NFκB) activity and the mRNA levels of proinflammatory cytokines and increasing mitochondrial DNA copy number and anti-oxidative stress genes expression in WT mice liver, in vivo and in vitro. Moreover, Celastrol induced hepatic Sirt1 expression in WT mice, in vivo and in vitro. These Celastrol-mediated protective effects in WT mice fed a HFD were abolished in LKO mice fed a HFD. It was more interesting that Celastrol aggravated HFD-induced liver damage in LKO mice fed a HFD by inhibiting the phosphorylation of AMPKα and boosting the translocation of NFκB into the nucleus, thereby resulting in the increase of Srebp-1c expression and the mRNA levels of liver proinflammatory cytokines. Celastrol ameliorates NAFLD by decreasing lipid synthesis and improving the anti-oxidative and anti-inflammatory status. And Sirt1 has an important role in Celastrol-ameliorating liver metabolic damage caused by HFD.

1 October 2018 in Biochemical and Biophysical Research Communications
Verified
Journal Article
Closed access
MGMingyue Gao
Mingyue Gao
WZWei Zhao
Wei Zhao
CLChunmei Li
Chunmei Li
XXXianghong Xie
Xianghong Xie
MLMeixia Li
Meixia Li
XLXiaojun Liu
Xiaojun Liu

29 June 2017 in Science China Life Sciences
Verified
Journal Article
Closed access
PDF file
CGChao Geng
Chao Geng
HXHaifeng Xu
Haifeng Xu
YZYinliang Zhang
Yinliang Zhang
YGYong Gao
Yong Gao
MLMeixia Li
Meixia Li
YCYongsheng Chang
Yongsheng Chang

1 September 2015 in Journal of Hepatology
Verified
Journal Article
Closed access
XLXiaojun Liu
Xiaojun Liu
YGYong Gao
Yong Gao
MLMeixia Li
Meixia Li
CGChao Geng
Chao Geng
HXHaifeng Xu
Haifeng Xu
YCYongsheng Chang
Yongsheng Chang

1 March 2016 in Biochemical and Biophysical Research Communications
Verified
Journal Article
Closed access
CGChao Geng
Chao Geng
YZYinliang Zhang
Yinliang Zhang
YGYong Gao
Yong Gao
WTWufan Tao
Wufan Tao
HZHuabing Zhang
Huabing Zhang
YCYongsheng Chang
Yongsheng Chang

8 November 2013 in PLOS ONE
Verified
Journal Article
Open access
PDF file
XLXiaojun Liu
Xiaojun Liu
YCYing Cui
Ying Cui
MLMeixia Li
Meixia Li
HXHaifeng Xu
Haifeng Xu
JZJin Zuo
Jin Zuo
YCYongsheng Chang
Yongsheng Chang
Reactive oxygen species arise in the mitochondria as byproducts of respiration and oxidase activity and have important roles in many physiological and pathophysiological conditions. The level of reactive oxygen species is regulated by a number of enzymes and physiological antioxidants, including HO-1, Sod2, catalase and COX-2, etc. And HO-1 against oxidative stress requires an increase in stress-responsive genes, such as Sod2 and catalase. Especially for the activity of HO-1, cobalt protoporphyrin is known to be a potent and effective inducer in many tissues. The transcription factor, FOXO1 is resistant to oxidative stress through downregulating reactive oxygen species production. Previous study showed that FOXO1 induces HO-1 expression by binding to HO-1 promoter. The question whether cobalt protoporphyrin induces HO-1 expression mediated by FOXO1 and subsequently lessens reactive oxygen species production remains to be elucidated. Cobalt protoporphyrin enhances the expression of FOXO1 and facilitates FOXO1 binding to HO-1 promoter and increasing its transcriptional activity without influencing the FOXO1 protein stability. CoPP induces HO-1 and other oxidative stress-responsive genes expression, such as catalase, cytochrome c, Sod2, and COX-2, and decreases mitochondria-derived reactive oxygen species production, which are mediated partially by FOXO1. Cobalt protoporphyrin induces HO-1 and other oxidative stress-responsive genes expression mediated partially by FOXO1, and has an important role in reducing cellular reactive oxygen species level. Cobalt protoporphyrin may be a more promising therapeutic agent to upregulate some antioxidantive genes.